CA
DXCM icon

Continuum Advisory’s DexCom DXCM Stock Holding History

Continuum Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-280
Closed -$19.1K – 713
2025
Q1 		$19.1K Sell
280
-15
-5% -$1.22K ﹤0.01% 865
2024
Q4 		$22.9K Buy
295
+2
+0.7% +$148 ﹤0.01% 818
2024
Q3 		$21.9K Buy
293
+32
+12% +$2.63K ﹤0.01% 822
2024
Q2 		$29.6K Buy
261
+4
+2% +$506 ﹤0.01% 719
2024
Q1 		$32.9K Buy
+257
New +$32.3K ﹤0.01% 681
2023
Q3 		– Sell
-1,630
Closed -$209K – 457
2023
Q2 		$209K Buy
+1,630
New +$197K 0.03% 426
2022
Q1 		– Sell
-1,668
Closed -$224K – 382
2021
Q4 		$224K Buy
1,668
+12
+0.7% +$1.72K 0.05% 275
2021
Q3 		$226K Buy
+1,656
New +$209K 0.06% 269

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Continuum Advisory's DXCM Position: Q2 2025 in Review

Continuum Advisory sold out of DexCom (DXCM) in Q2 2025, closing a stake of 280 shares — an estimated $19.1K sold.

Continuum Advisory first reported a position in DXCM in Q3 2021 and held it in 8 quarters. The position peaked at $226K in Q3 2021. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Continuum Advisory reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 280 DexCom shares in Q2 2025, an estimated $19.1K.
  • Continuum Advisory first reported a position in DexCom in Q3 2021 and held it in 8 quarters.
  • Continuum Advisory's DexCom position peaked at $226K in Q3 2021.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.